altretamine has been researched along with Cancer of Liver in 3 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pharmacokinetic studies (100-500 mg m-2) indicated that PMM plasma levels are dose-dependent and that the PMM disposition-phase half-life is prolonged in patients with abnormal liver function." | 2.65 | Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies. ( Harrap, KR; Muindi, JR; Newell, DR; Smith, IE, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joss, RA | 1 |
| Brunner, KW | 1 |
| Goldhirsch, A | 1 |
| Oldham, DS | 1 |
| Wampler, GL | 1 |
| Muindi, JR | 1 |
| Newell, DR | 1 |
| Smith, IE | 1 |
| Harrap, KR | 1 |
1 trial available for altretamine and Cancer of Liver
| Article | Year |
|---|---|
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Kinetics; | 1983 |
2 other studies available for altretamine and Cancer of Liver
| Article | Year |
|---|---|
Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Topics: Altretamine; Antineoplastic Agents; Carcinoma, Small Cell; Drug Therapy, Combination; Humans; Leukoc | 1982 |
Hexamethylmelamine in adenocarcinoma of the pancreas and liver.
Topics: Adenocarcinoma; Altretamine; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middl | 1983 |